25 results
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
7.2 STOCK CERTIFICATES; PARTLY PAID
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
of the Securities to the Purchasers on the terms and subject to the conditions set forth in this Agreement, the Company has entered into engagement … letters (the “Engagement Letters”), with each of Leerink Partners LLC, Piper Sandler & Co. and H.C. Wainwright & Co., LLC (the “Placement Agents
PRE 14A
idpoy574jrjo0eaij3
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.1
2aqp5mjvnk g9o
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
EX-99.1
g91gbbj7idd gtr
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
0sjtyp4r
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
10-K
lhraja08dcq6u1zqoa
22 Mar 19
Annual report
4:45pm
424B4
k5ft2o
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-3.4
tz41droc90uk z8p8g
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
twawcm
23 Jan 19
IPO registration (amended)
4:39pm